TNF receptors in chronic lymphocytic leukemia

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Two transmembrane receptors for tumor necrosis factor (TNF), p55 and p75, exist.
• Both receptors can be shed, forming soluble TNF receptors (sTNFR) that bind TNF in biological fluids.
• Normal B cells express TNF receptors (TNFR) and produce TNF, with p75 being dominant.

Purpose of the Study:

• To investigate the role of TNF and its receptors in chronic lymphocytic leukemia (CLL).
• To determine if TNF acts as an autocrine growth factor in CLL.
• To analyze the impact of soluble TNF receptors (sTNFR) on TNF's role in CLL progression.

Main Methods:

• Analysis of TNF and TNFR expression and function in normal B cells and CLL cells.
• Measurement of serum levels of soluble TNF receptors (sTNFR) in CLL patients.
• Assessment of TNF-induced DNA synthesis in CLL cells via both p55 and p75 receptors.

Main Results:

• CLL B cells produce TNF and express both p55 and p75 TNFR, with p75 being dominant.
• TNF stimulates DNA synthesis in CLL cells through both receptor types.
• Elevated serum sTNFR levels correlate with advanced CLL disease.

Conclusions:

• TNF likely functions as an autocrine growth factor in CLL.
• The net effect of TNF in CLL is influenced by the balance of cell-surface TNFR, plasma TNF, and sTNFR.
• The significance of TNF as a growth factor may diminish in advanced CLL due to increased sTNFR.